DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dario Paggiarino, MD
Senior Vice President, Chief Medical Officer, EyePoint Pharmaceuticals
Principal Investigator - Flavio Leonin, Jr., MD
Senior Manager, Clinical Affairs, EyePoint Pharmaceuticals
Study Director - Keyur Patel, PharmD
Vice President, Medical Affairs, EyePoint Pharmaceuticals
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Eye Center South Locations
Dothan, Alabama, United States
- Inland Eye Specialists
Hemet, California, United States
- Harvard Eye Associates
Laguna Hills, California, United States
- Coastal Vision Medical Group
Orange, California, United States
- North Bay Eye Associates, Inc.
Rohnert Park, California, United States
- the Eye Associates of Manatee, Llp
Bradenton, Florida, United States
- Eye Physicians of Pinellas, Pa, Dba the Eye Institute of West Florida
Largo, Florida, United States
- Jacksoneye, Sc
Lake Villa, Illinois, United States
- Hauser-Ross Eye Institute
Oak Brook, Illinois, United States
- Price Vision Group
Indianapolis, Indiana, United States
- Physicians Eyecare Center
Baltimore, Maryland, United States
- Discover Vision Centers
Independence, Missouri, United States
- Silverstein Eye Centers
Kansas City, Missouri, United States
- Tekwani Vision Center
St Louis, Missouri, United States
- Surgery Center of Central New Jersey
Pennington, New Jersey, United States
- Sightmd, Pllc
Hauppauge, New York, United States
- New York Eye Surgery Center
The Bronx, New York, United States
- Island Eye Surgicenter
Westbury, New York, United States
- Wills Surgery Center
Jenkintown, Pennsylvania, United States
- Vrf Eye Specialty Group
Memphis, Tennessee, United States
- Valley Retina Institute, Pa
McAllen, Texas, United States
- the Eye Centers of Racine and Kenosha
Racine, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Nov 2019
- Primary completion
- 1 May 2020
- Completion
- 1 May 2020
- Last update posted
- 26 May 2021
- Registered enrollment
- 527
- Registry id
- NCT04290676
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.